{"id":54730,"date":"2023-03-10T20:03:06","date_gmt":"2023-03-10T19:03:06","guid":{"rendered":"https:\/\/pharma-trend.com\/en\/amsurg-advocates-for-timely-colorectal-cancer-screening-and-education\/"},"modified":"2023-03-10T20:03:06","modified_gmt":"2023-03-10T19:03:06","slug":"amsurg-advocates-for-timely-colorectal-cancer-screening-and-education","status":"publish","type":"post","link":"https:\/\/pharma-trend.com\/en\/amsurg-advocates-for-timely-colorectal-cancer-screening-and-education\/","title":{"rendered":"AMSURG Advocates for Timely Colorectal Cancer Screening and Education"},"content":{"rendered":"
\n

NASHVILLE, Tenn.–(BUSINESS WIRE)–AMSURG, a division of Envision Healthcare and a national leader in outpatient care, is spreading awareness about colorectal cancer prevention and advocating for opportunities to improve screening rates and the health of communities across the country. As part of its efforts, AMSURG teams are engaging with legislators and industry leaders in Washington, D.C., March 10 and March 12-14.\n<\/p>\n

<\/a><\/p>\n

\nJohn Popp, MD, AMSURG Medical Director, has been invited to attend the Cancer Moonshot Colorectal Cancer Forum hosted by the White House on March 10. He will join industry leaders in addressing ways to improve colorectal cancer screening. The event follows the Biden-\u2060Harris Administration\u2019s recent announcement that it is reigniting the Cancer Moonshot<\/a>, which in part aims to increase colorectal cancer screening for people aged 45 to 75. The forum is scheduled from 3-5:30 p.m. ET, and a livestream can be viewed here<\/a>.\n<\/p>\n

\n\u201cI\u2019m honored to participate in the forum and collaborate with so many leaders dedicated to preventing and treating cancer,\u201d Dr. Popp said. \u201cWe are at a pivotal moment in healthcare. Colorectal cancer is the second leading cause of cancer death in the U.S., and it\u2019s on its way to becoming the leading cause. Fortunately, physicians are able to help people prevent colorectal cancer and identify it early, giving them a greater opportunity to survive and thrive. Our AMSURG team has been at the forefront of that initiative, providing colonoscopies to patients and educating people about timely screenings beginning at age 45 for average-risk individuals.\u201d\n<\/p>\n

\nIn addition, Brenda Thompson Green, a colon cancer survivor and AMSURG teammate, and Patrick Velliky, Vice President of Government Affairs for Envision Healthcare, along with a few AMSURG teammates, will be on Capitol Hill March 12-14, participating in Fight CRC\u2019s Call-on Congress<\/a>. They will help install flags on the National Mall, speak on AMSURG\u2019s colorectal cancer initiatives and talk to members of Congress.\n<\/p>\n

\n\u201cThe colorectal cancer facts are staggering \u2013 this year alone, 52,550 people are predicted to die<\/a> from it,\u201d Velliky said. \u201cThat\u2019s someone\u2019s family member, colleague, neighbor or friend, and we, as a nation, have the unique opportunity to help them live. Cancer survivors and champions help put a name and face to the disease and are essential to spreading awareness and impacting the future of thousands of people. Engaging with policymakers on enhanced screening efforts is an important part of the ongoing fight against colorectal cancer.\u201d\n<\/p>\n

\nAMSURG and its national network of gastroenterologists and colorectal surgeons performed more than 1 million colonoscopies in 2022<\/a>, helping people prevent, detect and overcome colorectal cancer. A colonoscopy is the most accurate and effective screening method. Colon cancer survivors and AMSURG leadership recently talked about the importance of colonoscopies in the following videos:\n<\/p>\n